NEW YORK (GenomeWeb) – Immunovia, a Swedish diagnostics company, said this week that it can distinguish patients suffering from systemic lupus erythematosus from those with other autoimmune diseases using its antibody array platform.

Laura Chirica, chief commercial officer at the Lund-based firm, said in an interview that Immunovia has used its flagship Immray microarray screening tool to look at about 400 samples from patients with SLE and other common autoimmune diseases, like rheumatoid arthritis, vasculitis, and Sjögren's syndrome.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.